Day One Biopharmaceuticals Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Day One Biopharmaceuticals Inc
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Day One Biopharmaceuticals Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Day One Biopharmaceuticals Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Day One Biopharmaceuticals Inc is DAWN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Day One Biopharmaceuticals Inc has its primary listing on NASDAQ. You can trade Day One Biopharmaceuticals Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Day One Biopharmaceuticals Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Day One Biopharmaceuticals Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Day One Biopharmaceuticals Inc.